| scholarly article | Q13442814 |
| P356 | DOI | 10.3174/AJNR.A5459 |
| P698 | PubMed publication ID | 29191870 |
| P50 | author | Alzheimer's Disease Neuroimaging Initiative | Q4738819 |
| Hugo Vrenken | Q57014777 | ||
| Martijn D Steenwijk | Q59809060 | ||
| Antoine Meijerman | Q89444834 | ||
| Houshang Amiri | Q89444837 | ||
| Marianne Jonker | Q89444840 | ||
| Ronald van Schijndel | Q89444843 | ||
| Keith Cover | Q89444847 | ||
| P2860 | cites work | Mild cognitive impairment: pathology and mechanisms. | Q24631255 |
| The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods | Q24647259 | ||
| Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 | ||
| Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease | Q26853610 | ||
| Revisiting brain atrophy and its relationship to disability in multiple sclerosis | Q28729953 | ||
| Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain | Q29614725 | ||
| Automatically parcellating the human cerebral cortex | Q29615077 | ||
| MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths | Q33411170 | ||
| Mechanisms of tau-induced neurodegeneration | Q33859830 | ||
| Highly accurate inverse consistent registration: a robust approach | Q34160493 | ||
| Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans | Q34201112 | ||
| Segmentation and volumetric analysis of the caudate nucleus in Alzheimer's disease. | Q34344114 | ||
| Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort | Q34738569 | ||
| Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI | Q34901300 | ||
| Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. | Q34986741 | ||
| Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials | Q35669030 | ||
| Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). | Q35781558 | ||
| Within-subject template estimation for unbiased longitudinal image analysis | Q36075413 | ||
| A Bayesian model of shape and appearance for subcortical brain segmentation | Q36158330 | ||
| Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration | Q36661880 | ||
| Quality criteria were proposed for measurement properties of health status questionnaires | Q36680196 | ||
| The neuropathological profile of mild cognitive impairment (MCI): a systematic review. | Q37964897 | ||
| Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases | Q38222379 | ||
| Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis | Q43806089 | ||
| A practical approach to Bland-Altman plots and variation coefficients for log transformed variables | Q46086156 | ||
| Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis. | Q46194628 | ||
| Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study | Q46309628 | ||
| Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease | Q48214660 | ||
| Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS. | Q48441438 | ||
| Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis. | Q48573150 | ||
| Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis. | Q48625729 | ||
| Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. | Q49161447 | ||
| Cortical and subcortical atrophy in Alzheimer disease: parallel atrophy of thalamus and hippocampus. | Q50897053 | ||
| Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST. | Q51112453 | ||
| Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group | Q73187378 | ||
| Statistical models for assessing agreement in method comparison studies with replicate measurements | Q83773170 | ||
| Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally | Q87419738 | ||
| P433 | issue | 1 | |
| P921 | main subject | reproducibility | Q1425625 |
| P304 | page(s) | 46-53 | |
| P577 | publication date | 2017-11-30 | |
| P1433 | published in | American Journal of Neuroradiology | Q15762571 |
| P1476 | title | Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset | |
| P478 | volume | 39 |
| Q92519607 | The striatum, the hippocampus, and short-term memory binding: Volumetric analysis of the subcortical grey matter's role in mild cognitive impairment |
| Q94111359 | Untangling normal aging from disease-related brain atrophy in MS |
| Q55502196 | Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. |
| Q58588249 | Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines |
Search more.